Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AG-RASAGILINE DIN 02514532

Status: Approved
Holder: ANGITA PHARMA INC.
Molecule: RASAGILINE (RASAGILINE MESYLATE)

Health Canada record

Active ingredient(s)RASAGILINE (RASAGILINE MESYLATE) 0.5 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN04BD02 RASAGILINE
Original market date
Current status date09-Apr-2021
SourceHealth Canada DPD

Establishment licence of the holder

Angita Pharma Inc. — licence 101870, currently licensed, last inspection rating C (2025-01-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing RASAGILINE (RASAGILINE MESYLATE)

DINProductCompanyFormStrengthStatus
02514540AG-RASAGILINEANGITA PHARMA INC.TabletRASAGILINE (RASAGILINE MESYLATE) 1 MGApproved
02404680APO-RASAGILINEAPOTEX INCTabletRASAGILINE (RASAGILINE MESYLATE) 0.5 MGMarketed
02404699APO-RASAGILINEAPOTEX INCTabletRASAGILINE (RASAGILINE MESYLATE) 1 MGMarketed
02489139ASN-RASAGILINEASCEND LABORATORIES LTDTabletRASAGILINE (RASAGILINE MESYLATE) 1 MGApproved
02489120ASN-RASAGILINEASCEND LABORATORIES LTDTabletRASAGILINE (RASAGILINE MESYLATE) 0.5 MGApproved
02284642AZILECTTEVA CANADA LIMITEDTabletRASAGILINE (RASAGILINE MESYLATE) 0.5 MGMarketed
02284650AZILECTTEVA CANADA LIMITEDTabletRASAGILINE (RASAGILINE MESYLATE) 1 MGMarketed
02491974JAMP RASAGILINEJAMP PHARMA CORPORATIONTabletRASAGILINE (RASAGILINE MESYLATE) 0.5 MGMarketed
02491982JAMP RASAGILINEJAMP PHARMA CORPORATIONTabletRASAGILINE (RASAGILINE MESYLATE) 1 MGMarketed
02533723MINT-RASAGILINEMINT PHARMACEUTICALS INCTabletRASAGILINE (RASAGILINE MESYLATE) 0.5 MGApproved
02533731MINT-RASAGILINEMINT PHARMACEUTICALS INCTabletRASAGILINE (RASAGILINE MESYLATE) 1 MGApproved
02418444TEVA-RASAGILINETEVA CANADA LIMITEDTabletRASAGILINE (RASAGILINE MESYLATE) 1 MGMarketed
02418436TEVA-RASAGILINETEVA CANADA LIMITEDTabletRASAGILINE (RASAGILINE MESYLATE) 0.5 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
256372021-04-09Abbreviated New Drug Submission (ANDS)LICENSING AGREEMENT BETWEEN TWO COMPANIES
Request a quote for AG-RASAGILINE

How to read a Canadian DIN record